News & Updates
Filter by Specialty:
Hepatitis C reinfection rates up in direct-acting antiviral era
26 Feb 2022
There is an increased rate of hepatitis C virus (HCV) reinfection among people who inject drugs after the scale-up of direct-acting antivirals, reports a recent Scotland study.
Hepatitis C reinfection rates up in direct-acting antiviral era
26 Feb 2022STRIDE regimen boosts OS in unresectable HCC
25 Feb 2022
byRoshini Claire Anthony
The addition of tremelimumab to durvalumab (STRIDE regimen) in the first-line setting improved overall survival (OS) compared with sorafenib in patients with advanced unresectable hepatocellular carcinoma (HCC), according to results of the phase III HIMALAYA trial.
STRIDE regimen boosts OS in unresectable HCC
25 Feb 2022Sarcoidosis patients at risk of haematologic, nonmelanoma skin cancers
25 Feb 2022
Sarcoidosis patients with biopsy-verified non-necrotizing granulomatous inflammation are at greater risk of haematologic cancers and nonmelanoma skin cancer (NMSC) in the long term than the general population, a study has found.